Streamlined design of a self-inactivating feline immunodeficiency virus vector for transducing ex vivo dendritic cells and T lymphocytes

Genetic Vaccines and Therapy

Volumn 5, Issue , 2007, Pages

  Pistello, Mauro ^a   Vannucci, Laura ^a   Ravani, Alessia ^a   Bonci, Francesca ^a   Chiuppesi, Flavia ^a   Del Santo, Barbara ^a   Freer, Giulia ^a   Bendinelli, Mauro ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GREEN FLUORESCENT PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; POL PROTEIN; REV PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL MATURATION; CELL STRAIN 3T3; CELL TYPE; CONTROLLED STUDY; DENDRITIC CELL; EX VIVO STUDY; FELINE IMMUNODEFICIENCY VIRUS; FIBROBLAST; GENE INSERTION; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HEPATITIS VIRUS; HUMAN; HUMAN CELL; IMMUNIZATION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; REPORTER GENE; T LYMPHOCYTE; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS INACTIVATION; VIRUS PARTICLE; VIRUS TYPING;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; MARMOTA MONAX; MURINAE; VESICULAR STOMATITIS VIRUS;

EID: 36148934211     PISSN: None     EISSN: 14790556     Source Type: Journal    
DOI: 10.1186/1479-0556-5-8     Document Type: Article

References (47)

1. Figdor CG de Vries IJ Lesterhuis WJ Melief CJ Dendritic cell immunotherapy: Mapping the way Nat Med 2004, 10:475-480 15122249
2. Randolph GJ Angeli V Swartz MA Dendritic-cell trafficking to lymph nodes through lymphatic vessels Nat Rev Immunol 2005, 5:617-628 16056255
3. Marathe JG Wooley DP Is gene therapy a good therapeutic approach for HIV-positive patients? Genet Vaccines Ther 2007, 5:5 1810294 17300725
4. Palucka AK Laupeze B Aspord C Saito H Jego G Fay J Paczesny S Pascual V Banchereau J Immunotherapy via dendritic cells Adv Exp Med Biol 2005, 560:105-114 15932026
5. Wu Q Xia D Carlsen S Xiang J Adenovirus-mediated transgene-engineered dendritic cell vaccine of cancer Curr Gene Ther 2005, 5:237-247 15853731
6. Jooss K Chirmule N Immunity to adenovirus and adeno-associated viral vectors: Implications for gene therapy Gene Ther 2003, 10:955-963 12756416
7. Kafri T Gene delivery by lentivirus vectors an overview Methods Mol Biol 2004, 246:367-390 14970605
8. Buffa V Negri DR Leone P Borghi M Bona R Michelini Z Compagnoni D Sgadari C Ensoli B Cara A Evaluation of a self-inactivating lentiviral vector expressing simian immunodeficiency virus gag for induction of specific immune responses in vitro and in vivo Viral Immunol 2006, 19, 690-701 17201664
9. Chinnasamy N Treisman JS Oaks MK Hanson JP Chinnasamy D Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination Gene Ther 2005, 12:259-271 15668698
10. He Y Zhang J Mi Z Robbins P Falo LD Jr Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity J Immunol 2005 174, 3808-3817 15749922
11. Kung SK Bonifacino A Metzger ME Ringpis GE Donahue RE Chen IS Lentiviral vector-transduced dendritic cells induce specific T cell response in a nonhuman primate model Hum Gene Ther 2005, 16:527-532 15871684
12. Romano G Current development of lentiviral-mediated gene transfer Drug News Perspect 2005, 18:128-134 15883621
13. Sparger EE FIV as a model for HIV: An overview In vivo Models of HIV Infection and Control Bendinelli. New York: Springer Friedman H, Specter S 2006, 149-237
14. Curran MA Kaiser SM Achacoso PL Nolan GP Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors Mol Ther 2000 1:31-38 10933909
15. Poeschla EM Wong-Staal F Looney DJ Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors Nat Med 1998, 4:354-357 9500613
16. Price MA Case SS Carbonaro DA Yu XJ Petersen D Sabo KM Curran MA Engel BC Margarian H Abkowitz JL Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells Mol Ther 2002, 6:645-652 12409263
17. Pistello M Moscardini M Mazzetti P Bonci F Zaccaro L Isola P Freer G Specter S Matteucci D Bendinelli M Development of feline immunodeficiency virus ORF-A (tat) mutants: In vitro and in vivo characterization Virology 2002, 298:84-95 12093176
18. de Parseval A Elder JH Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial rev activity J Virol 1999, 73:608-617 103867 9847366
19. Mustafa F Jayanth P Phillip PS Ghazawi A Schmidt RD Lew KA Rizvi TA Relative activity of the feline immunodeficiency virus promoter in feline and primate cell lines Microbes Infect 2005, 7:233-239 15725384
20. Bigornia L Lockridge KM Sparger EE Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses J Virol 2001, 75:1054-1060 114003 11134320
21. Whitwam T Peretz M Poeschla E Identification of a central DNA flap in feline immunodeficiency virus J Virol 2001, 75:9407-9414 114508 11533203
22. Browning MT Mustafa F Schmidt RD Lew KA Rizvi TA Sequences within the gag gene of feline immunodeficiency virus (FIV) are important for efficient RNA encapsidation Virus Res 2003, 93:199-209 12782368
23. Kemler I Barraza R Poeschla EM Mapping the encapsidation determinants of feline immunodeficiency virus J Virol 2002, 76:11889-11903 136900 12414931
24. Sandrin V Boson B Salmon P Gay W Negre D Le Grand R Trono D Cosset FL Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates Blood 2002, 100;823-832 12130492
25. Munz C Steinman RM Fujii S Dendritic cell maturation by innate lymphocytes: Coordinated stimulation of innate and adaptive immunity J Exp Med 2005, 202:203-207 16027234
26. Pistello M Bonci F Flynn JN Mazzetti P Isola P Zabogli E Camerini V Matteucci D Freer G Pelosi P Bendinelli M AIDS vaccination studies with an ex vivo feline immunodeficiency virus model: Analysis of the accessory ORF-A protein and DNA as protective immunogens J Virol 2006, 80:8856-8868 1563914 16940498
27. Matteucci D Pistello M Mazzetti P Giannecchini S Isola P Merico A Zaccaro L Rizzuti A Bendinelli M AIDS vaccination studies using feline immunodeficiency virus as a model: Immunisation with inactivated whole virus suppresses viraemia levels following intravaginal challenge with infected cells but not following intravenous challenge with cell-free virus Vaccine 1999, 18:119-130 10501242
28. Loewen N Barraza R Whitwam T Saenz DT Kemler I Poeschla EM FIV Vectors Methods Mol Biol 2003, 229:251-271 12824636
29. Stevenson M HIV nuclear import: What's the flap? Nat Med 2000, 6:626-628 10835671
30. Saenz DT Poeschla EM FIV: From lentivirus to lentivector J Gene Med 2004, 6(Suppl 1):S95-104 14978754
31. Mustafa F Ghazawi A Jayanth P Phillip PS Ali J Rizvi TA Sequences intervening between the core packaging determinants are dispensable for maintaining the packaging potential and propagation of feline immunodeficiency virus transfer vector RNAs J Virol 2005, 79:13817-13821 1262595 16227303
32. Segura MM Kamen A Garnier A Downstream processing of oncoretroviral and lentiviral gene therapy vectors Biotechnol Adv 2006 24 321 337 16448798
33. Zhang B Xia HQ Cleghorn G Gobe G West M Wei MQ A highly efficient and consistent method for harvesting large volumes of high-titre lentiviral vectors Gene Ther 2001, 8:1745-1751 11892843
34. Landazuri N Le Doux JM Complexation with chondroitin sulfate C and polybrene rapidly purifies retrovirus from inhibitors of transduction and substantially enhances gene transfer Biotechnol Bioeng 2006, 93:146-158 16240439
35. Kang Y Moressi CJ Scheetz TE Xie L Tran DT Casavant TL Ak P Benham CJ Davidson BL McCray PB Jr Integration site choice of a feline immunodeficiency virus vector J Virol 2006, 80:8820-8823 1563849 16912328
36. Monse H Laufs S Kuate S Zeller WJ Fruehauf S Uberla K Viral determinants of integration site preferences of simian immunodeficiency virus-based vectors J Virol 2006, 80:8145-8150 1563816 16873270
37. Montini E Cesana D Schmidt M Sanvito F Ponzoni M Bartholomae C Sergi Sergi L Benedicenti F Ambrosi A Di Serio C Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration Nat Biotechnol 2006, 24:687-696 16732270
38. Sauter SL Gasmi M FIV vector systems Somat Cell Mol Genet 2001, 26:99-129 12465464
39. De Palma M Montini E Santoni de Sio FR Benedicenti F Gentile A Medico E Naldini L Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells Blood 2005, 105:2307-2315 15542582
40. Johnston JC Gasmi M Lim LE Elder JH Yee JK Jolly DJ Campbell KP Davidson BL Sauter SL Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors J Virol 1999, 73:4991-5000 112543 10233961
41. D'Souza V Summers MF How retroviruses select their genomes Nat Rev Microbiol 2005, 3:643-655 16064056
42. Moscardini M Pistello M Bendinelli M Ficheux D Miller JT Gabus C Le Grice SF Surewicz WK Darlix JL Functional interactions of nucleocapsid protein of feline immunodeficiency virus and cellular prion protein with the viral RNA J Mol Biol 2002, 318:149-159 12054775
43. Zufferey R Donello JE Trono D Hope TJ Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors J Virol 1999, 73:2886-2892 104046 10074136
44. Seganti L Superti F Girmenia C Melucci L Orsi N Study of receptors for vesicular stomatitis virus in vertebrate and invertebrate cells Microbiologica 1986, 9:259-267 3018449
45. DePolo NJ Reed JD Sheridan PL Townsend K Sauter SL Jolly DJ Dubensky TW Jr VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum Mol Ther 2000, 2:218-222 10985952
46. Verhoeyen E Cosset FL Surface-engineering of lentiviral vectors J Gene Med 2004, 6(Suppl 1):S83-94 14978753
47. Sandrin V Cosset FL Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein J Biol Chem 2006, 281:528-542 16195228